Trump's pick to lead VA testifies he opposes privatization in first Senate confirmation hearing

VA secretary nominee Robert Wilkie had his first Senate confirmation hearing on Wednesday. (Senate Veterans Affairs Committee)

President Donald Trump's pick to lead the Department of Veterans Affairs, Robert Wilkie, told senators on Wednesday that he would oppose efforts to privatize the VA health system as he testified in the first of his confirmation hearings for the job.

Under questioning before the Senate Veterans Affairs Committee from Sen. Bernie Sanders, I-Vt., Wilkie said he believes in the "centrality" of the VA in caring for the nation's veterans. "My commitment to you is that I will oppose efforts to privatize the VA," said Wilkie, a Department of Defense official who was appointed to head the Department of Veterans Affairs last month.

Privatization of the VA's health system is likely to be center stage as Wilkie's nomination makes its way through the Senate. The previous VA secretary, David Shulkin, M.D., said he was fired from the position because the Trump administration viewed him as an "obstacle" to privatization. 

Conference

2019 Drug Pricing and Reimbursement Stakeholder Summit

Given federal and state pricing requirements arising, press releases from industry leading pharma companies, and the new Drug Transparency Act, it is important to stay ahead of news headlines and anticipated requirements in order to hit company profit targets, maintain value to patients and promote strong, multi-beneficial relationships with manufacturers, providers, payers, and all other stakeholders within the pricing landscape. This conference will provide a platform to encourage a dialogue among such stakeholders in the pricing and reimbursement space so that they can receive a current state of the union regarding regulatory changes while providing actionable insights in anticipation of the future.

Trump tapped Wilkie to head to the VA after former White House doctor Ronny Jackson took his name out of consideration amid allegations of on-the-job misconduct. Jackson also said he would oppose privatization

RELATED: VA's Clancy—Secretary nominee Wilkie has 'healthcare squarely on his brain' 

Wilkie, if confirmed, will take over the VA as it rolls out the recently passed MISSION Act, which reforms the beleaguered Veterans Choice program and allows a veteran to seek care outside of the VA system if his or her doctor approves. He said that his belief that the VA is central to caring for veterans plays into how he views the Veterans Choice program, saying it is fair to ease access barriers by allowing veterans to see private doctors as long as they're also interacting regularly with the VA system. 

"Many of the issues I encountered as acting secretary were not with the quality of care but were getting veterans through the door to get that care," Wilkie said. 

Wilkie named several other priorities he'll focus on if confirmed, including the VA's ongoing rollout of its new electronic health record system, reforming business operations and human resources and addressing a backlog of claims. The lack of leadership at the top of the VA has hindered the rollout of the new Cerner EHR. Wilkie said it is crucial for him to hit the ground running on that issue. 

RELATED: VA signs $10B deal with Cerner, but implementation challenges loom large 

The EHR updates will provide a template for automating the claims process, Wilkie said, and will better allow for interoperability between the VA, the DOD and other providers. Plus, he said, it will allow the VA to harness analytics to get out in front of some of the biggest issues impacting veterans. 

"It's our opportunity to turn the corner and be an industry leader on opioid use, intervention and suicide prevention," Wilkie said. 

Suggested Articles

Researchers at two universities plan to develop an autonomous trauma care system that uses robotics and artificial intelligence to treat soldiers.

A change to the government’s voluntary bundled payment model for oncology is going to be bad news for many participants.

CMS Administrator Seema Verma said it will be crucial to have more conversations on how to address emerging—and expensive—therapies.